lf 1695 has been researched along with piperidines in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Annat, J; Derrepas, P; Dutartre, P; Pascal, M | 1 |
| Othman, O; Pascal, M; Sanhadji, K; Touraine, JL | 1 |
| Chap, H; Douste-Blazy, L; Hullin, F; Pascal, M; Ragab-Thomas, JM; Sepulchre, C | 1 |
| Touraine, JL | 1 |
| Othmane, O; Pascal, M; Sanhadji, K; Touraine, JL | 1 |
| Derrepas, P; Pascal, M | 1 |
| Capron, A; Joseph, M; Pascal, M; Thorel, T; Vorng, H | 1 |
1 review(s) available for lf 1695 and piperidines
| Article | Year |
|---|---|
Effect of the immunomodulator LF 1695 on T-lymphocytes and macrophages. Activity in HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adjuvants, Immunologic; Humans; Macrophages; Piperidines; T-Lymphocytes | 1989 |
6 other study(ies) available for lf 1695 and piperidines
| Article | Year |
|---|---|
Implications of prostaglandin E2 synthesis and phospholipase C activation in potentiation of T-cell proliferation by LF 1695.
Topics: Animals; Calcimycin; Calcium; Cells, Cultured; Concanavalin A; Dinoprostone; Inositol Phosphates; Lymphocyte Activation; Mice; Piperidines; Signal Transduction; Spleen; T-Lymphocytes; Tetradecanoylphorbol Acetate; Type C Phospholipases | 1991 |
A new immunomodulator, LF 1695--II. Effects on allogenic and antigenic responses.
Topics: Animals; Dose-Response Relationship, Drug; Graft vs Host Reaction; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Piperidines; Spleen; Thymidine; Transplantation, Homologous | 1991 |
Stimulation of 12-HETE production in human platelets by an immunomodulator, LF 1695. Evidence for activation of arachidonate liberation coupled to cyclo-oxygenase inhibition.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; 5,8,11,14-Eicosatetraynoic Acid; Adjuvants, Immunologic; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Calcimycin; Cyclooxygenase Inhibitors; Humans; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombin | 1989 |
A new immunomodulator, LF 1695--I. In vitro effects on the T lymphocyte lineage in man.
Topics: Adjuvants, Immunologic; Antigens, Differentiation, T-Lymphocyte; Antigens, Surface; Bone Marrow Cells; Cell Differentiation; Humans; Lymphocyte Activation; Phenotype; Piperidines; Stem Cells; T-Lymphocytes; T-Lymphocytes, Regulatory | 1985 |
Increased interleukin-1 and modulation of interleukin-2 production by murine macrophages and lymphocytes treated with LF 1695.
Topics: Animals; Dinoprostone; Female; In Vitro Techniques; Interleukin-1; Interleukin-2; Lectins; Leukotriene B4; Lymphocyte Activation; Macrophages; Mice; Mice, Inbred Strains; Piperidines; Prostaglandins E; T-Lymphocytes | 1986 |
In vitro and in vivo immunomodulation by LF 1695 of human and rat macrophages and platelets in schistosomiasis.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Helminth; Blood Platelets; Cytotoxicity, Immunologic; Female; Humans; In Vitro Techniques; Interleukin-1; Macrophages; Male; Piperidines; Rats; Schistosoma mansoni; Schistosomiasis mansoni | 1988 |